American Research & Management Company’s GoodRx Holdings GDRX Stock Holding History

American Research & Management Company’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$1K	Hold	191	–	–	﹤0.01%	395
2022 Q2	$1K	Hold	191	–	–	﹤0.01%	379
2022 Q1	$4K	Hold	191	–	–	﹤0.01%	350
2021 Q4	$6K	Hold	191	–	–	﹤0.01%	331
2021 Q3	$8K	Hold	191	–	–	﹤0.01%	312
2021 Q2	$7K	Hold	191	–	–	﹤0.01%	328
2021 Q1	$7K	Buy	191 +180	+1,636%	+$8.1K	﹤0.01%	310
2020 Q4	$0	Buy	+11	New	+$505	﹤0.01%	376

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSCM

Light Street Capital Management Palo Alto, California $903M AUM 113.12% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TCMX

Technology Crossover Management X Menlo Park, California $795M AUM 5.23% 1-Year Est. Return

American Research & Management Company's GDRX Position: Q3 2022 in Review

American Research & Management Company held its GoodRx Holdings (GDRX) position steady in Q3 2022 at 191 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

American Research & Management Company first reported a position in GDRX in Q4 2020 and has held it in 8 quarters since. The position peaked at $8K in Q3 2021. 180 funds tracked by Wall St. Rank hold GDRX as of Q3 2022.

American Research & Management Company held 191 shares of GoodRx Holdings worth $1K as of Q3 2022.
American Research & Management Company left its GoodRx Holdings share count unchanged in Q3 2022.
GoodRx Holdings made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #395 holding.
American Research & Management Company first reported a position in GoodRx Holdings in Q4 2020 and has held it in 8 quarters since.
American Research & Management Company's GoodRx Holdings position peaked at $8K in Q3 2021.
180 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.